BE905568R - Procede et dispositif d'administration transdermique de medicament. - Google Patents

Procede et dispositif d'administration transdermique de medicament.

Info

Publication number
BE905568R
BE905568R BE0/217267A BE217267A BE905568R BE 905568 R BE905568 R BE 905568R BE 0/217267 A BE0/217267 A BE 0/217267A BE 217267 A BE217267 A BE 217267A BE 905568 R BE905568 R BE 905568R
Authority
BE
Belgium
Prior art keywords
medicament
transdermal administration
skin
rate
analgesia
Prior art date
Application number
BE0/217267A
Other languages
English (en)
Inventor
Robert M Gale
Victor Goetz
Eun S Lee
Lina T Taskovich
Su Il Yum
Goetz Victor
Yum Su Il
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24541036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE905568(R) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of BE905568R publication Critical patent/BE905568R/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procédé pour induire et maintenir une analgésie, comprenant l'administration à travers une superficie de peau intacte, d'une forme pour laquelle la peau est perméable d'une matière choisie parmi le groupe comprenant du fentanyl et ses dérivés efficaces du point de vue analgésique, à un débit efficace du point de vue analgésique, et la poursuite de l'adminstration de cette matière à ce débit pendant une péiode de temps prolongée suffisante pour induire l'analgésie.
BE0/217267A 1984-07-23 1986-10-07 Procede et dispositif d'administration transdermique de medicament. BE905568R (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06633762 US4588580B2 (en) 1984-07-23 1984-07-23 Transdermal administration of fentanyl and device therefor

Publications (1)

Publication Number Publication Date
BE905568R true BE905568R (fr) 1987-02-02

Family

ID=24541036

Family Applications (2)

Application Number Title Priority Date Filing Date
BE0/215347A BE902884A (fr) 1984-07-23 1985-07-12 Procede et dispositif d'aministration transdermique de medicament
BE0/217267A BE905568R (fr) 1984-07-23 1986-10-07 Procede et dispositif d'administration transdermique de medicament.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BE0/215347A BE902884A (fr) 1984-07-23 1985-07-12 Procede et dispositif d'aministration transdermique de medicament

Country Status (13)

Country Link
US (1) US4588580B2 (fr)
JP (1) JP2547726B2 (fr)
BE (2) BE902884A (fr)
CA (1) CA1245983A (fr)
CH (1) CH665351A5 (fr)
CY (1) CY1560A (fr)
DE (1) DE3526339A1 (fr)
ES (2) ES8802276A1 (fr)
FR (1) FR2567761B1 (fr)
GB (1) GB2165148B (fr)
HK (1) HK8191A (fr)
IT (1) IT1183912B (fr)
NL (1) NL8501979A (fr)

Families Citing this family (275)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US5132114A (en) * 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
DE3682165D1 (de) * 1985-11-08 1991-11-28 Nitto Denko Corp Verwendung von heftpflastern fuer die haut und perkutanen praeparaten.
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
DE3775830D1 (de) * 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4822802A (en) * 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4981782A (en) * 1987-05-14 1991-01-01 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
US4853227A (en) * 1987-10-23 1989-08-01 Ciba-Geigy Corporation Transdermal administration of a systemic active agent to a premature neonatal infant
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US5064654A (en) * 1989-01-11 1991-11-12 Ciba-Geigy Corporation Mixed solvent mutually enhanced transdermal therapeutic system
US5925372A (en) * 1987-12-16 1999-07-20 Novartis Corporation Mixed solvent mutually enhanced transdermal therapeutic system
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US4891377A (en) * 1988-12-02 1990-01-02 Board Of Regents Acting For And On Behalf Of University Of Michigan Transdermal delivery of the narcotic analgesics etorphine and analogs
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
US5268179A (en) * 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
ATE185694T1 (de) * 1992-05-13 1999-11-15 Alza Corp Oxybutynin zur transdermalen verabreichung
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
JPH08512054A (ja) * 1993-06-25 1996-12-17 アルザ・コーポレーション 経皮系におけるポリ−ｎ−ビニルアミドの含有
US5750137A (en) * 1993-09-29 1998-05-12 Taskovich; Lina Tormen Monoglyceride/lactate ester permeation enhancer
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
US7027859B1 (en) * 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
DE69512083T2 (de) 1994-11-17 2000-03-30 Alza Corp., Palo Alto Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
US5843014A (en) * 1995-03-24 1998-12-01 Alza Corporation Display for an electrotransport delivery device
US5879322A (en) * 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
ZA964320B (en) * 1995-06-05 1997-01-13 Alza Corp Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6245347B1 (en) * 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
US5667799A (en) * 1995-10-30 1997-09-16 Caldwell; Larry J. Method for treating headache pain with topical local anesthetic compositions
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
US6660295B2 (en) 1997-09-30 2003-12-09 Alza Corporation Transdermal drug delivery device package with improved drug stability
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
US6050988A (en) * 1997-12-11 2000-04-18 Alza Corporation Device for enhancing transdermal agent flux
DE69839969D1 (de) 1997-12-11 2008-10-16 Alza Corp Vorrichtung zur verbesserung des transdermalen flusses von medikamenten
DE69831268T2 (de) * 1997-12-11 2006-03-09 Alza Corp., Palo Alto Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
EP1911488A3 (fr) 1997-12-11 2008-12-03 Alza Corporation Dispositif pour améliorer le flux d'agent transdermique
EP1041975B1 (fr) 1997-12-22 2002-09-04 Alza Corporation Membranes de regulation de debit pour dispositifs d'administration regulee de medicaments
US6103771A (en) * 1998-03-20 2000-08-15 Caldwell Galer Incorporated Method of treating neuroma pain
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
US6858018B1 (en) 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
US6348210B1 (en) 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
EP2158903A3 (fr) 1998-12-18 2010-04-14 ALZA Corporation Dispositifs d'administration de nicotine transdermique transparente
GB9828480D0 (en) * 1998-12-24 1999-02-17 Dermatech Limited Transdermal drug delivery system
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
US6541021B1 (en) 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
WO2001068140A2 (fr) * 2000-03-10 2001-09-20 Durect Corporation Formulations opioides
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
AU778081B2 (en) * 1999-03-25 2004-11-11 Tepha, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
AU3932600A (en) * 1999-04-01 2000-10-23 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
WO2001015671A2 (fr) 1999-08-30 2001-03-08 Tepha, Inc. Produits polymeres jetables dans les toilettes
KR20010036685A (ko) 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
EP1239916B1 (fr) 1999-12-10 2005-11-23 ALZA Corporation Dispositif et procede d'amelioration de percage de peau par micro-protuberances
EA200200839A1 (ru) 2000-02-08 2003-04-24 Эро-Селтик, С.А. Композиции с контролируемым высвобождением, содержащие агонист и антагонист опиоидов
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
NZ524396A (en) * 2000-07-31 2003-09-26 Nycomed Danmark As Fentanyl composition for nasal administration comprising water as a solvent
KR100940245B1 (ko) * 2000-09-19 2010-02-04 내쇼날 스타치 앤드 케미칼 인베스트멘트 홀딩 코포레이션 경피 약물 전달 시스템에 유용한 비반응성 접착제
US20020119187A1 (en) 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE20221247U1 (de) 2001-03-16 2005-09-15 Alza Corp Transdermal-Pflaster zum Verabreichen von Fentanyl
ATE364380T1 (de) * 2001-03-16 2007-07-15 Alza Corp Transdermales pflaster zur verabreichung von fentanyl
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
WO2003032983A1 (fr) * 2001-06-05 2003-04-24 Ronald Aung-Din Therapie antimigraineuse par voie transdermique
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US20030068375A1 (en) * 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
CA2460352C (fr) * 2001-08-17 2013-05-14 Lavipharm Laboratories Inc. Composition et dispositif d'administration transdermique de medicaments
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
KR100844312B1 (ko) * 2001-09-06 2008-07-07 노사케미컬(주) 펜타닐 경피 투여 제제
ATE501712T1 (de) * 2002-04-23 2011-04-15 Durect Corp Transdermale analgetische systeme mit reduziertem missbrauchspotential
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE10223835A1 (de) 2002-05-28 2003-12-11 Labtec Gmbh Pflaster, enthaltend Fentanylum
AU2003243896B2 (en) 2002-05-28 2008-07-03 Labtec Gesellschaft Fur Technologische Forschung Und Entwicklung Mbh Plaster containing fentanyl
US7157102B1 (en) 2002-05-31 2007-01-02 Biotek, Inc. Multi-layered microcapsules and method of preparing same
US7041320B1 (en) 2002-05-31 2006-05-09 Biotek, Inc. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
EP2266565A1 (fr) 2002-06-10 2010-12-29 Euro-Celtique S.A. Systèmes d'élimination de dispositifs d'alimentation transdermique pour empêcher une mauvaise utilisation d'agents actifs contenus dans celui-ci
US7771707B2 (en) 2004-06-12 2010-08-10 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8246979B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
AU2003268376A1 (en) * 2002-08-30 2004-11-26 Watson Pharmaceuticals, Inc. Transdermal delivery systems and methods
WO2004024155A1 (fr) * 2002-09-13 2004-03-25 Hisamitsu Pharmaceutical Co., Inc. Pastille adhesive
AU2003270778B2 (en) * 2002-09-20 2009-10-08 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
AU2003285934A1 (en) * 2002-10-25 2004-05-25 Euro-Celtique S.A. Analogs and prodrugs of buprenorphine
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
CA2513402A1 (fr) * 2003-02-07 2004-08-19 Walter Mueller Systeme therapeutique transdermique apte a une application thermique visant a augmenter la permeation de substances actives, et utilisation associee
US20060062812A1 (en) * 2003-03-11 2006-03-23 Calvin Ross Novel compositions
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
US7834147B2 (en) 2003-04-28 2010-11-16 Childrens Hospital Medical Center Saposin C-DOPS: a novel anti-tumor agent
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
CL2004000927A1 (es) * 2003-04-30 2005-01-28 Purdue Pharma Lp Forma de dosificacion transdermica que comprende un agente activo, una superficie proxima y una superficie distal.
ES2819189T3 (es) 2003-05-08 2021-04-15 Tepha Inc Tejidos y fibras médicos de polihidroxialcanoato
JP5137286B2 (ja) * 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
WO2004112723A2 (fr) * 2003-06-20 2004-12-29 Ronald Aung-Din Therapie locale pour le traitement des migraines, des claquages musculaires, des spasmes musculaires, de la spasticite et d'etats apparentes
JP2007528853A (ja) * 2003-07-08 2007-10-18 テファ， インコーポレイテッド 徐放性薬物送達のためのポリ−４−ヒドロキシブチレートマトリックス
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US20060287659A1 (en) * 2003-08-22 2006-12-21 Tepha, Inc. Polyhydroxyalkanoate nerve regeneration devices
EP2269606A3 (fr) 2003-10-30 2012-04-25 ALZA Corporation Systèmes analgésiques transdermiques disposant d'un potentiel d'abus réduit
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
US7867511B2 (en) 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
JP2007523167A (ja) 2004-02-23 2007-08-16 ユーロ−セルティーク エス．エイ． 乱用抵抗性の経皮的オピオイド送達デバイス
US20050255150A1 (en) * 2004-04-26 2005-11-17 Cassel Douglas R Wound treatment patch for alleviating pain
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
US7641825B2 (en) * 2004-08-03 2010-01-05 Tepha, Inc. Method of making a polyhydroxyalkanoate filament
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
JP4824963B2 (ja) * 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
US8252319B2 (en) * 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
CN101146523B (zh) * 2004-10-21 2010-12-29 杜雷科特公司 透皮给药系统
ES2362221T3 (es) * 2005-01-28 2011-06-29 Tepha, Inc. Embolización con partículas poli-4-hidroxibutirato.
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
US7309809B2 (en) * 2005-02-26 2007-12-18 Xennovate Medical Llc Adhesive attachment and removal device
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
US7297149B2 (en) 2005-04-14 2007-11-20 Ethicon Endo-Surgery, Inc. Surgical clip applier methods
US8038686B2 (en) 2005-04-14 2011-10-18 Ethicon Endo-Surgery, Inc. Clip applier configured to prevent clip fallout
US7288098B2 (en) 2005-04-14 2007-10-30 Ethicon Endo-Surgery, Inc. Force limiting mechanism for medical instrument
US8523882B2 (en) 2005-04-14 2013-09-03 Ethicon Endo-Surgery, Inc. Clip advancer mechanism with alignment features
US7261724B2 (en) 2005-04-14 2007-08-28 Ethicon Endo-Surgery, Inc. Surgical clip advancement mechanism
US7686820B2 (en) * 2005-04-14 2010-03-30 Ethicon Endo-Surgery, Inc. Surgical clip applier ratchet mechanism
US7740641B2 (en) 2005-04-14 2010-06-22 Ethicon Endo-Surgery, Inc. Clip applier with migrational resistance features
US20060257461A1 (en) * 2005-05-13 2006-11-16 Jansen Rolf R Multilayer galantamine delivery system with barrier against reservoir material flow
WO2006133101A2 (fr) * 2005-06-03 2006-12-14 Trans-Dermal Patents Company, Llc Systeme d'administration d'agent
US20090143761A1 (en) * 2005-06-03 2009-06-04 Transdermal Patents Company, Llc Agent delivery system and uses of same
US20070098772A1 (en) * 2005-09-23 2007-05-03 Westcott Tyler D Transdermal norelgestromin delivery system
WO2007035941A2 (fr) * 2005-09-23 2007-03-29 Alza Corporation Systeme d'administration transdermique de galantamine
EP2308480B1 (fr) 2005-09-23 2014-08-13 ALZA Corporation Formulation de polyacrylate hautement chargée en activateur pour des applications transdermiques
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US7888422B2 (en) * 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
EP1956985A2 (fr) * 2005-11-23 2008-08-20 Universität Zürich Traitement d'une allergie par administration épicutanée d'un allergène
US20070202156A1 (en) * 2006-02-13 2007-08-30 Aveva Drug Deliverty Systems Adhesive preparation comprising sufentanil and methods of using same
US8518926B2 (en) * 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
US20070248657A1 (en) * 2006-04-25 2007-10-25 Smith David J Multi-compartment transdermal pain control device
BRPI0710945A2 (pt) 2006-04-28 2012-03-13 Children's Hospital Medical Center Propriedades fusogênicas de saposina c e proteínas e peptídeos relacionados para aplicação a sistemas de distribuição de fármaco transmembrana
CA2652251A1 (fr) 2006-05-16 2007-11-29 Knopp Neurosciences, Inc. Compositions de r(+) et s(-) pramipexole et procedes d'utilisation de celles-ci
US20070278289A1 (en) * 2006-05-31 2007-12-06 Toshiba Tec Kabushiki Kaisha Payment adjusting apparatus and program therefor
PT2034975E (pt) * 2006-06-19 2012-06-25 Alpharma Pharmaceuticals Llc Composições farmacêuticas
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
KR101486599B1 (ko) * 2006-07-14 2015-01-26 히사미쓰 세이야꾸 가부시키가이샤 첩부제
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
PT2117521E (pt) * 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
AU2008224844B2 (en) * 2007-03-14 2012-08-09 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
MX354603B (es) 2007-05-25 2018-03-13 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
CN104398496B (zh) * 2007-10-15 2018-03-20 阿尔扎公司 芬太尼的一天更换一次透皮施用
US8577624B2 (en) * 2007-12-12 2013-11-05 Aarhus Universitet Crystal structure of a plasma membrane proton pump
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
CA3066426A1 (fr) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Compositions pharmaceutiques renfermant un antiemetique et un analgesique opioide
KR101829920B1 (ko) 2008-01-28 2018-02-19 데이고꾸세이약꾸가부시끼가이샤 펜타닐 함유 외용 패치
EP2111857A1 (fr) * 2008-04-25 2009-10-28 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
ES2596435T3 (es) * 2008-05-21 2017-01-09 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
ES2680222T3 (es) 2008-05-22 2018-09-05 H. Lundbeck A/S Modulación de los receptores con dominio Vps10p para el tratamiento de la enfermedad cardiovascular
US8460657B2 (en) 2008-06-25 2013-06-11 H. Lundbeck A/S Modulation of the TrpV: Vps10p receptor system for the treatment of pain
US8592424B2 (en) 2008-06-30 2013-11-26 Afgin Pharma Llc Topical regional neuro-affective therapy
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
US8637075B2 (en) 2008-09-12 2014-01-28 Pharma Gp Aps Colostrum composition
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
US8703125B2 (en) 2008-12-19 2014-04-22 H. Lundbeck A/S Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
WO2010095537A1 (fr) * 2009-02-18 2010-08-26 久光製薬株式会社 Préparation transdermique
CN102802418A (zh) * 2009-06-19 2012-11-28 诺普神经科学股份有限公司 用于治疗肌萎缩性侧索硬化的组合物和方法
EP2451274B1 (fr) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Compositions pharmaceutiques
EP2295046B1 (fr) 2009-09-14 2012-12-19 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
US8267945B2 (en) 2009-10-09 2012-09-18 Ethicon Endo-Surgery, Inc. Clip advancer with lockout mechanism
DE102009048973A1 (de) * 2009-10-09 2011-04-14 Beiersdorf Ag Transdermale therapeutische Systeme enthaltend 4-n-Butylresorcin
US8262679B2 (en) 2009-10-09 2012-09-11 Ethicon Endo-Surgery, Inc. Clip advancer
WO2011054359A2 (fr) 2009-11-06 2011-05-12 University Of Copenhagen Méthode de détection précoce du cancer
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2011095174A1 (fr) 2010-02-08 2011-08-11 Aarhus Universitet Polypeptides et polynucléotides u20 des virus de l'herpès humain 6 et 7 pour une utilisation en tant que médicament ou diagnostic
WO2011107100A1 (fr) 2010-03-03 2011-09-09 Aarhus Universitet Procédés et compositions pour la régulation de herv4
AU2011239636A1 (en) 2010-04-13 2012-11-22 Najib Babul Dermal pharmaceutical compositions of 1-Methyl-2',6'-pipecoloxylidide and method of use
WO2011135531A2 (fr) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. DISPOSITIFS MÉDICAUX POUR L'ADMINISTRATION D'ARNsi
WO2012046149A1 (fr) 2010-04-28 2012-04-12 Kimberly-Clark Worldwide, Inc. Procédé d'augmentation de la perméabilité d'une barrière épithéliale
JP5860032B2 (ja) 2010-04-28 2016-02-16 キンバリー クラーク ワールドワイド インコーポレイテッド 関節リウマチ薬の送達のためのデバイス
PT2563453T (pt) 2010-04-28 2017-03-15 Kimberly Clark Co Dispositivo medicinal possuindo uma nanoforma com melhor interacção celular e um método para a sua formação
JP2013532144A (ja) 2010-06-14 2013-08-15 ハー・ルンドベック・アクチエゼルスカベット ＳｏｒＬＡとＧＤＮＦファミリーリガンド受容体の間の相互作用の調節
CN104873455B (zh) 2010-12-22 2023-09-12 普渡制药公司 包覆的抗篡改控制释放剂型
CN103327969A (zh) 2010-12-23 2013-09-25 普渡制药公司 抗篡改固体口服剂型
DK2665741T3 (en) 2011-01-10 2019-04-29 Invion Inc APPLICATION OF BETA-ADRENERGE INVERSE AGONISTS FOR SMOKE CLEANING
US8696637B2 (en) 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8781571B2 (en) 2011-03-31 2014-07-15 Incline Therapeutics, Inc. Switch validation circuit and method
US9731121B2 (en) 2011-03-31 2017-08-15 Incline Therapeutics, Inc. Switch validation circuit and method
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
CN103930098B (zh) 2011-09-22 2017-06-06 株式会社三养生物制药 含有芬太尼及其同族体的经皮吸收制剂
BR112014005534A2 (pt) 2011-09-30 2017-06-13 Teikoku Pharma Usa Inc sistema de descarte de curativo transdérmico
KR20140067042A (ko) 2011-09-30 2014-06-03 테이코쿠 팔마 유에스에이, 인코포레이티드 일반 약물 처리 시스템
EP2768418B1 (fr) 2011-10-19 2017-07-19 Ethicon Endo-Surgery, Inc. Applicateur d'agrafe conçu pour être utilisé avec un robot chirurgical
KR102265775B1 (ko) 2011-10-27 2021-06-16 소렌토 쎄라퓨틱스, 인코포레이티드 고점도 생체활성 제제의 경피 전달 방법
JP6004594B2 (ja) 2011-11-15 2016-10-12 ジ ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ 可溶性メディエーター
EP2599478A1 (fr) * 2011-11-30 2013-06-05 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
WO2013096816A1 (fr) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Synthèse améliorée de composés substitués par amine de 4,5,6,7-tétrahydrobenzothiazole
EP2812640B1 (fr) 2012-02-10 2018-08-08 Carrier Corporation Procédé de détection de perte de fluide frigorifique
CA3120681C (fr) 2012-04-17 2024-05-28 Purdue Pharma L.P. Systemes et procedes de traitement d'une reponse pharmacodynamique indesirable induite par un opioide
EP2846822A2 (fr) 2012-05-11 2015-03-18 Prorec Bio AB Méthode de diagnostic et de traitement de troubles associés à la prolactine
EP2919759A4 (fr) 2012-11-14 2016-07-20 Ohio State Innovation Foundation Matières et procédés utiles pour le traitement du glioblastome
WO2014123899A1 (fr) 2013-02-05 2014-08-14 Purdue Pharma L.P. Formulations pharmaceutiques inviolables
CA2939259C (fr) 2013-02-11 2021-01-26 Glycanova As Creme derivee de basidiomycete pour le traitement de maladies cutanees
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
WO2014164754A1 (fr) 2013-03-11 2014-10-09 Durect Corporation Composition injectable à libération contrôlée comprenant un véhicule liquide à haute viscosité
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9682068B2 (en) 2013-05-20 2017-06-20 Mylan Inc. Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
PT2810646T (pt) 2013-06-04 2016-10-05 Lts Lohmann Therapie Systeme Ag Sistema de administração transdérmica
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
DK3019167T3 (da) 2013-07-12 2021-03-15 Knopp Biosciences Llc Behandling af forhøjede niveauer af eosinophiler og/eller basophiler
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
WO2015023790A1 (fr) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions et méthodes pour le traitement de l'urticaire chronique
EP3039042A1 (fr) 2013-08-29 2016-07-06 University of Copenhagen Anticorps anti-adam12 pour le traitement du cancer
WO2016025329A1 (fr) 2014-08-15 2016-02-18 Tepha, Inc. Sutures auto-rétentive de poly-4-hydroxybutyrate et de copolymères de celui-ci
US9849124B2 (en) 2014-10-17 2017-12-26 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
EP3233081B1 (fr) * 2014-12-19 2021-09-22 Kindeva Drug Delivery L.P. Dispositif d'administration transdermique de médicament, comprenant du fentanyl
WO2016112271A1 (fr) 2015-01-08 2016-07-14 The Johns Hopkins University Compositions et procédés d'accélération de la résolution d'une inflammation pulmonaire aiguë
EP3265081A4 (fr) 2015-03-02 2018-11-21 Afgin Pharma, Llc Thérapie neuro-affective régionale topique comprenant des cannabinoïdes
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
CA3055170A1 (fr) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Compositions pharmaceutiques
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
US10377114B2 (en) 2017-04-20 2019-08-13 Inep Europe Sarl Method for making a transdermal fentanyl patch with even drug crystal distribution
US11052054B2 (en) 2017-04-19 2021-07-06 Inep Europe Sarl Method for manufacturing a transdermal device
US10391065B2 (en) 2017-04-19 2019-08-27 Inep Europe Sarl Method for making a transdermal fentanyl patch with even drug crystal distribution
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
JP6912122B2 (ja) * 2019-02-28 2021-07-28 日本臓器製薬株式会社 経皮投与製剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL107185C (fr) * 1957-12-19
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
AR207805A1 (es) * 1975-02-06 1976-10-29 Alza Corp Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4127127A (en) * 1977-05-23 1978-11-28 Alza Corporation Therapeutic systems made from certain segmented copolyesters
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5594316A (en) * 1979-01-11 1980-07-17 Key Pharma Diffusion matrix for medicine release
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS5919926B2 (ja) * 1980-01-16 1984-05-09 日東電工株式会社 薬物投与部材
JPS5714522A (en) * 1980-06-09 1982-01-25 Key Pharma Polymer diffused matrix
JPS57123117A (en) * 1981-01-23 1982-07-31 Nitto Electric Ind Co Ltd Administration of drug from adhesive preparation
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
US4725272A (en) * 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
JPS5919926A (ja) * 1982-07-27 1984-02-01 Canon Inc 可変焦点カメラ
US4486423A (en) * 1983-04-21 1984-12-04 Janssen Pharmaceutica Inc. Stable fentanyl composition
JPS60185713A (ja) * 1984-03-05 1985-09-21 Nitto Electric Ind Co Ltd 経皮吸収性製剤及びその製法
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers

Also Published As

Publication number Publication date
US4588580B2 (en) 1999-02-16
FR2567761A1 (fr) 1986-01-24
AU565177B2 (en) 1987-09-10
AU4452785A (en) 1986-01-30
IT1183912B (it) 1987-10-22
ES557179A0 (es) 1987-08-16
ES545366A0 (es) 1988-05-01
GB2165148B (en) 1989-05-17
HK8191A (en) 1991-02-01
CH665351A5 (de) 1988-05-13
GB2165148A (en) 1986-04-09
IT8567666A0 (it) 1985-07-22
ES8707667A1 (es) 1987-08-16
ES8802276A1 (es) 1988-05-01
NL8501979A (nl) 1986-02-17
JPS6137725A (ja) 1986-02-22
US4588580B1 (fr) 1989-01-03
BE902884A (fr) 1985-11-04
DE3526339A1 (de) 1986-01-30
JP2547726B2 (ja) 1996-10-23
CY1560A (en) 1991-03-22
FR2567761B1 (fr) 1988-12-02
GB8514445D0 (en) 1985-07-10
US4588580A (en) 1986-05-13
CA1245983A (fr) 1988-12-06
DE3526339C2 (fr) 1992-01-09

Similar Documents

Publication Publication Date Title
BE905568R (fr) Procede et dispositif d'administration transdermique de medicament.
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
MY108496A (en) Hypoglycemic thiazolidine diones.
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
FR2527450B1 (fr) Procede et dispositif de traitement therapeutique par transmission d'une substance active a travers la peau
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
FR2719999B1 (fr) Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
BE890808A (fr) Nouvelle forme galenique d'administration de metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
ATE47664T1 (de) Pharmazeutische dosierungseinheit.
FR2626178B1 (fr) Procede et appareil de preparation d'un solute medicamenteux contenant des radicaux libres et son application therapeutique
FR2653343B1 (fr) Procede et dispositif de sauvetage et de protection d'un etre humain.
FR2635978B3 (fr) Composition therapeutique d'application cutanee pour le traitement des hyperpigmentations melaniques acquises et destinee a l'eclaircissement des peaux pigmentees
BG102182A (en) The use of ipriflavon for reducing the number of cd8+ cells
IT1179244B (it) Dispositivo per irrigazioni, in particolare irrigazioni, medicate, dentarie o vaginali e simili
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ALZA CORP.

Effective date: 20050712

RE20 Patent expired

Owner name: *ALZA CORP.

Effective date: 20050712